Mechanism of L-alpha-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2)

Pharm Res. 1990 Dec;7(12):1313-9. doi: 10.1023/a:1015906409585.

Abstract

The Caco-2 model system (Hidalgo et al., Gastroenterology, 96:736-749, 1989), which is a monolayer of polarized intestinal epithelial cells grown onto a porous polycarbonate membrane, was used to study the mechanism of transcellular transport of an antihypertensive agent, L-alpha-methyldopa (L-alpha-MD). The results showed that the transport of L-alpha-MD was pH, glucose, concentration, and temperature dependent, and it could be inhibited by metabolic inhibitors (e.g., 2,4-dinitrophenol) and by amino acids (e.g., L-phenylalanine) which have an affinity for the large neutral amino acid (LNAA) carrier. In addition, the apparent kinetic constants describing the transcellular transport of L-alpha-MD were altered depending on the time interval between feeding the cells and the transport experiments (postfeeding time, PFT). The apparent maximum carrier flux (Jmax) of L-alpha-MD was significantly increased (from 155 to 547 pmol/mg protein/min) when PFT was prolonged from 8.5 to 56 hr. These results indicated that the transcellular transport of L-alpha-MD through the polarized Caco-2 cell monolayer was carrier mediated via the LNAA carrier. The similarities in the characteristics of L-alpha-MD transport exhibited by the Caco-2 model system and other intestinal models in vitro further substantiate the usefulness of this cell culture model for studying the intestinal transport of nutrients and drugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2,4-Dinitrophenol
  • Antihypertensive Agents / pharmacokinetics*
  • Biological Transport / drug effects
  • Carrier Proteins / metabolism
  • Cell Line
  • Dinitrophenols / pharmacology
  • Epithelial Cells
  • Epithelium / metabolism
  • Glucose
  • Humans
  • Hydrogen-Ion Concentration
  • Intestinal Mucosa / metabolism*
  • Intestines / cytology
  • Levodopa / analogs & derivatives*
  • Levodopa / pharmacokinetics
  • Models, Biological
  • Phenylalanine / pharmacology
  • Protein Binding
  • Temperature

Substances

  • Antihypertensive Agents
  • Carrier Proteins
  • Dinitrophenols
  • Levodopa
  • Phenylalanine
  • Glucose
  • levodopa methyl ester
  • 2,4-Dinitrophenol